Reply to Can quantified pathologic response assessed as residual tumor burden be a promising staging system for patients with rectal cancer treated with chemoradiation followed by surgery?
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Dipen M
DM
Maru
Atin A
AA
Agarwal
Chung-Yuan
CY
Hu
George J
GJ
Chang
D000230:Adenocarcinoma / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000473:pathology* / Q000628:therapy*; D018365:Neoplasm, Residual / Q000473:pathology* / Q000628:therapy*; D012004:Rectal Neoplasms / Q000473:pathology* / Q000628:therapy*